In a surprising turn of events, Regeneron has announced its acquisition of 23andMe for $256 million following the company's bankruptcy. The pharma giant aims to leverage 23andMe's vast customer data for drug discovery while prioritizing privacy and security.
The ISS faces a resupply crisis after a Cygnus mission is scrubbed due to damage, while 23andMe's bankruptcy prompts panic among customers eager to delete their genetic data.
As 23andMe files for bankruptcy, users scramble to delete their sensitive data due to fears of their genetic information being sold. The company struggles to handle the surge in requests amidst ongoing privacy concerns.
Oregon's attorney general calls for consumers to take control of their genetic data following 23andMe's Chapter 11 bankruptcy filing. Learn how to delete your data and revoke permissions.
In light of 23andMe's financial struggles, California Attorney General Rob Bonta reminds residents of their rights to delete genetic data. Learn how to safeguard your sensitive information today!
In a dramatic turn of events, 23andMe has filed for Chapter 11 bankruptcy, leading to the immediate resignation of CEO Anne Wojcicki. The company plans to sell its assets while navigating financial turmoil and ongoing efforts to safeguard customer data.